Article
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
20 Mar 2020
Abstract excerpt
Platinum-based anticancer drugs, including cisplatin, carboplatin, oxaliplatin, nedaplatin, and lobaplatin, are heavily applied in chemotherapy regimens. However, the intrinsic or acquired resistance severely limit the clinical application of platinum-based treatment. The underlying mechanisms are incredibly complicated. Multiple transporters participate in the active transport of platinum-based antitumor agents,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
